Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LHC-165 is an agonist of TLR7. It also has the potential to treat solid tumors.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,970.00 | |
50 mg | 10-14 weeks | $ 2,570.00 | |
100 mg | 10-14 weeks | $ 3,890.00 |
Description | LHC-165 is an agonist of TLR7. It also has the potential to treat solid tumors. |
Molecular Weight | 603.55 |
Formula | C29H32F2N3O7P |
CAS No. | 1258595-14-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1M NaOH: 50 mg/mL (82.84 mM), when pH is adjusted to 12 with NaOH. Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LHC-165 1258595-14-0 Immunology/Inflammation TLR LHC 165 LHC165 inhibitor inhibit